N-(2-(5-(6-aminopyridin-3-yl)thiazol-2-ylamino)-2-oxoethyl)-N-phenylisonicotinamide

ID: ALA2397304

Chembl Id: CHEMBL2397304

PubChem CID: 71681727

Max Phase: Preclinical

Molecular Formula: C23H20N6O2S

Molecular Weight: 444.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc(-c2cnc(NC(=O)CN(Cc3ccccc3)C(=O)c3ccncc3)s2)cn1

Standard InChI:  InChI=1S/C23H20N6O2S/c24-20-7-6-18(12-26-20)19-13-27-23(32-19)28-21(30)15-29(14-16-4-2-1-3-5-16)22(31)17-8-10-25-11-9-17/h1-13H,14-15H2,(H2,24,26)(H,27,28,30)

Standard InChI Key:  UQGXIBZKHFGPLN-UHFFFAOYSA-N

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

rhinovirus B5 (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus A45 (17 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus A89 (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus A2 (409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human rhinovirus 1A (153 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus A16 (69 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhinovirus B14 (1052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.52Molecular Weight (Monoisotopic): 444.1368AlogP: 3.46#Rotatable Bonds: 7
Polar Surface Area: 114.10Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.84CX Basic pKa: 5.97CX LogP: 2.13CX LogD: 2.08
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -1.53

References

1. Décor A, Grand-Maître C, Hucke O, O'Meara J, Kuhn C, Constantineau-Forget L, Brochu C, Malenfant E, Bertrand-Laperle M, Bordeleau J, Ghiro E, Pesant M, Fazal G, Gorys V, Little M, Boucher C, Bordeleau S, Turcotte P, Guo T, Garneau M, Spickler C, Gauthier A..  (2013)  Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus.,  23  (13): [PMID:23726345] [10.1016/j.bmcl.2013.04.077]

Source